Adriamycin (ADM)-encapsulated thermosensitive liposomes (ts-lip-ADM) and common liposomes (lip-ADM
Blood brain barrier (BBB) exists as a selective diffusion barrier. BBB is composed of specific structures by brain capillary endothelial cells and its sheathing by astrocytic endfeet through basement membrane, which maintained homeostasis of central nerve system (CNS) by its specific properties. The distinct anatomical feature of BBB is characterized as endothelial tight junctions, which is the main obstruction preventing substance from the blood transporting into the brain. 1) Most of hydrophilic drugs with poor BBB permeability cannot be transported easily across the BBB to produce a significant therapeutic efficiency.
Different methods have been used to facilitate the transporting of drugs into the brain. These methods include medicinal chemistry or barrier disruption and neurosurgical based invasive brain drug delivery. [2] [3] [4] [5] Since the invasive procedures are by nature severely limited, most of the methods usually used are characterized by osmotic biologically active agents. 6) Recently, additional drug delivery system have been studied for BBB delivery, such as liposomes, microcapsules and osmotic pumps. 7) To obtain better targeting efficiency, targeted liposomes and immunoliposomes have been proposed. 8, 9) Thermosensitive liposomes acts as novel carrier in virtue of physical mechanism which displayed drug is easily released from thermosensitive liposomes (ts-lip) when heating over its phase-transition temperature (T c ). Therefore thermosensitive liposomes combined with hyperthermia, which was heated up to 41-45°C with infrared light, a hot-water bath, supersonic wave, radio frequency and microwaves, can realize specific site targeting. 10) On one hand, hyperthermia can enhance tumor blood flow and microvascular permeability. On the other hand, thermosensitive liposomes have an enhanced permeation and retention effect for tumor vasculature combined with hyperthermia treatment. 11) It has been shown that drug encapsulated in thermosensitive liposomes accumulates more efficiently in tumors heated at 42°C than in unheated tumors. 12) In this study, combination of hyperthermia and thermosensitive liposomes was attempted to improve drug delivery to brain across BBB. Thermosensitive liposomes and common liposomes containing adriamycin hydrochloride (ADM) were prepared at first, and then a primary in vitro BBB model was established. Furthermore, the permeability of thermosensitive liposomes, common liposomes and drug solution were investigated on this model. At the same time, C6 gliomabearing mice model was developed and used to evaluate body distribution and anti-tumor efficacy in vivo.
MATERIALS AND METHODS

Materials
Adriamycin hydrochloride (ADM) was provided by Synbias Pharm Ltd. In this work ADM-encapsulated liposomes was provided with the following lipid composition: 1,2-distearyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-mPEG 2000 ), Dipalmitoyl phosphatidylcholine (DPPC) and Egg yolk phosphatidylcholine (EPC), (purity Ͼ99%, Lipoid Co., Ludwigshafen, Germany); monostearyl phosphatidylcholine (MSPC) (purity Ͼ99%, Avanti Polar Lipids, Albaster, Alabama, U.S.A.) and cholesterol (CHOL), (Beijing Chemical Agent Co., Beijing, China). All other chemicals and solvents, which were purchased from Beijing Chemical Agent Co. (China), were of analytical or HPLC grade. Rabbit anti-human fibillary acid protein multiclonal antibody and tetramethyl rho- 13) Briefly, phospholipids were dissolved in chloroform, then the solvent was evaporated at 60°C to form a dry film. The dried lipid films were hydrated with 200 mM citrate buffer (pH 4.0). And then, the suspensions were extruded through polycarbonate membranes (Whatman) of size 0.1 mm using a extruder (Avestin EmulsiFlex-C3, Avestin Inc., Ottawa, Ontario, Canada) to obtain blank liposomes. After the pH of blank liposomes was adjusted to pH 7.8 by Na 2 CO 3 , ADM solution was slowly added. The resulting ts-lip-ADM and lip-ADM were incubated at 35°Cfor about 30 min with wild stirring.
Quantification of ADM The encapsulation efficiency was determined by HPLC analysis with a Waters HPLC system(Dual l Absorbance Detector 2487, Binary Pump 1525, Waters, U.S.A.), using a reversed phase column (4.6ϫ250 mm, 5 mm; Agela Technologies, Inc., Boston, MA, U.S.A.). The mobile phase was methanol : 10 mm phosphate buffer (75 : 25, v/v, pH 7.4) with a flow rate of 1.0 ml/min.
The in vitro and in vivo analysis of samples were performed in LC-MS/MS consisted of an Agilent 6410 Triple Quad MS (electron spray ionization (ESI)) and an Agilent 1200 HPLC system (Agilent Technologies, Santa Clara, CA, U.S.A.). The separation of ADM and daunorubicin (internal standard) was achieved by automated injection of 5 ml samples into a reversed phase C 18 analytical column (Agela Venusil MP C18, 2.1ϫ50 mm, 3 mm, Agela Technologies, Inc., Boston, MA, U.S.A.) under isocratic conditions which contained methanol and water with 0.1% formyl acid (56 : 44, v/v) at a flow rate of 0.25 ml/min.
Characterization of ts-lip-ADM and lip-ADM The medium particle size (D50) and particle size distribution (Span) of liposomes were evaluated by dynamic light scattering (DLS) technique with a laser light scattering size analyzer (Smypatec Nanophox, Sympatec GmbH, ClausthalZellerfeld, Germany). The D50 and Span were measured for three times. Span was calculated by the equation below:
The morphology of the liposomes was observed by transmission electron microscopy (TEM, JEM-1010, Jeol Ltd., Tokyo, Japan).
The T cs of liposomes were measured with differential scanning calorimetry (Q100 differential scanning calorimeter, TA Instruments, New Castle, DE, U.S.A.). The samples were crimped into aluminum pans, and subjected to a heat/cool/ heat cycle between 0°C and 80°C. Heating and cooling rates were 10°C/min and a steady stream of nitrogen gas was supplied at 20 ml/min. The T c was calculated from the second heating cycle by analysis software supplied by the instrument manufacture.
Determination of the Encapsulation Efficiency (EE) Ultrafiltration method was used to separate free ADM and drug-loaded liposomes. After the separation, the total amount of ADM liposomes and free ADM were analyzed by the HPLC method described above. The ADM encapsulated efficiency was calculated by the following equation: encapsulation efficiency (%) ϭ(total amount of ADMϪfree ADM)/total amount of ADMϫ100%
Temperature-Dependent ADM Release from Loaded Liposomes in Vitro In vitro, drug release study was conducted under 37°C and 42°C, respectively to examine thermo-sensitivity of ts-lip-ADM and lip-ADM. Briefly, 2 ml of liposomes sample was placed into 20 ml saline solution, stirred and incubated at 37°C and 42°C, respectively. At various time intervals, aliquot samples were withdrawn and separated by ultrafiltration method, the concentration of free ADM was measured by HPLC method. The percentage of ADM released from loaded liposomes was defined as follows:
Where x 0 and x t represent the initial and intermediary amount of free ADM, respectively. x 100% is the total free ADM of a complete release sample. The complete release sample was prepared by adding methanol into liposomes suspensions.
Isolation and Characterization of Rat Astrocytes (As) 14, 15) The isolation procedure of astrocytes from rat brain was as follows: the cortex of brain of SD rat 12 h after birth was dissected free of meanings, cut away and minced into 1-2 mm cube, then centrifuged at a speed of 1000 rpm/min for 10 min. The sediments were digested in 0.25% trypsin at 37°C for 20 min. The tissue was further dispersed into free cells by using pipette in Dulbecco's modified Eagle's medium (DMEM, Sigma-Aldrich, St. Louis, MO, U.S.A.). Then the tissue was collected and centrifuged at a speed of 1000 rpm/min for 10 min. The tissue residues were collected. After forced through a 75 mm filter and centrifuged, the collected cells were re-suspended in DMEM containing 10% fetal calf serum (FCS). The cells were seeded at a density of 1.5ϫ10 6 cells/ml on plastic flask which was placed upside down and the flask was turned over 1 h later. The medium was changed every 3 d. After 9-10 d, the flasks were shaken at the speed of 180-260 rpm/min at 37°C for 18 h to eliminate floating cells. The purified astrocytes were refreshed with culture medium and allowed to reach confluence. Astrocytes were then subpassaged at a density of 3ϫ10 4 cells/ml. Astrocytes were seeded at second passage on the coverslip in 12 well plate. After 2-3 d culture, astrocytes were fixed by neutral formalin for 10 min. Then phosphate buffer solution (PBS) containing 0.3% triton-100 (v/v) and 5% bovine serum albumin (BSA, w/v) was added to rupture cell mem- brane. After treated by rabbit anti-human fibillary acid protein multiclonal antibody overnight at 4°C, astrocytes were treated by TRITC-conjugated goat anti-rabbit IgG for 3 h at 37°C. The cell specimen was viewed with fluorescence microscope. Establishment of the in Vitro BBB Model 16) ECV304 and astrocytes were cocultured in a "contact through feet" model. In a 12-well cell culture insert with 1 mm-diameter microporous polyethylene terephthalate (PET) membrane (Falcon, 1 mm pore size, 10.5 mm diameter, 0.9 cm 2 surface area), astrocytes were transferred at second passage on the bottom side at a density of 1.0ϫ10 6 cells/ml by placing the insert upside down. After 4 h, the astrocytes attached firmly, and then the membrane was turned over and placed in 12-well culture plate. DMEM supplemented 10% FCS was added and changed every other day. After 24 h, ECV304 were seeded on the upper side of membrane at a concentration of 2.0ϫ10 5 cells per insert. In the following days, transendothelial electrical resistance (TEER) was measured (Millicell ERS, Millipore, Bedford, U.S.A.) and the coculture was used for experiment.
The TEER At the end of the desired growth period, the plates were removed from the incubator and allowed to equilibrate to room temperature (approximately 0.5 h). Electrical resistance across ECV304/As cultured on the cell insert was measured using Millicell ERS system ohm meter.
Permeability of the BBB Model 14) ADM was selected as an indicator to evaluate the permeability of the BBB model. Confluent ECV304/As was selected as the BBB model, which was judged by TEER primarily. ECV304 alone was selected as the controlled BBB model. ADM was dissolved in the experimental culture medium (DMEM without FCS). The primary culture medium in the donor chamber was substituted by 500 ml experimental culture medium containing 10 mg ADM, and 1500 ml experimental culture medium was added into the acceptor chamber so that the liquid inside and outside of the cell insert were at the same level to avoid hydrostatic pressure. Samples of 500 ml were taken from the acceptor chamber at 5.0 h and replaced by 500 ml of fresh experimental culture medium each time. Cells were kept under culture conditions (37°C, 5% CO 2 , and saturated humidified atmosphere) during the whole transporting experiment. The samples were collected and kept at Ϫ70°C. At the end of the experiment, the collected samples were measured by LC-MS/MS. The percentage of permeability was calculated using the following formula:
C is the concentration of ADM obtained from the standard cure, V acceptor is 1.5 ml, V donor is 0.5 ml, C acceptor is 20.0 mg/ml.
Transport Measurements of ADM Liposomes In order to study the influence of liposomes or hyperthermia on the permeability of ADM on the BBB, several groups were set: ts-lip-ADM (42°C), lip-ADM (42°C), ADM (42°C), ts-lip-ADM (37°C), lip-ADM (37°C) and ADM (42°C). In each group, ADM was 10.0 mg in the donor chamber. After ADM added into donor chamber, plates of 42°C and 37°C groups were immediately incubated at 42°C and 37°C, respectively. Samples of 500 ml were taken from the acceptor chamber at a given interval time: 30 min, 60 min, 90 min, 120 min, and replaced by 500 ml of fresh experimental culture medium.Permeability percent (P %) was calculated to evaluate the effect of hyperthermia and liposomes on transporting ADM across BBB. ADM was determined by LC-MS/MS. Permeability coefficients were determined by the following equation:
Where P is the permeability coefficient, x is the amount of substance (ng) in the acceptor chamber at time (T, min), A is the area of the cell insert (cm 2 ), and C donor is the concentration of the drug in the donor chamber (ng/cm 3 ). Establishment of Glioma-Bearing Mice Model C6 cells were expanded and maintained in DMEM supplemented with 10% heat-inactivated FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin and cultured at 37°C under a humidified atmosphere containing 5% CO 2 . The viable cells, determined by trypan blue exclusion, were diluted to a concentration of 1.0ϫ10 8 cells/ml. The mice were anesthetized with a peritoneal injection of a solution of 10% chloral hydrate at a dose of 5 ml/kg. The posterior cranial region was shaved and prepared in a sterile fashion. After fixed on stereotaxis instrument, a midline incision approximately 0.5 cm in length was made at the convergence of the head midline and intercanthal line. A skull hole was drilled at bregma using a steel drill bit at 1.8 mm to the right of sagittal suture. C6 glioma cell suspension (4ϫ10 5 cells in 4 ml PBS) was injected using a 22-gauge 10 ml Hamilton syringe at a depth of 3.0 mm into the brain. After surgery, the animals were allowed to recover under observation and then returned to their cage.
Body Distribution Seven days after surgery, 54 gliomabearing mice were IV injected (tail vein) with ts-lip-ADM, lip-ADM and ADM at a drug dose of 10 mg/kg. After administration the heads of mice were heated in water bath at 42°C for 30 min. In each treatment group, mice were sacrificed at 0.5, 1, 2 h after drug administration (nϭ6 at each time point). Blood samples were collected before injection and at sacrificing. The following organs were removed completely at sacrificing: brain, kidney, heart, lung, liver and spleen. Each specimen was weighted and frozen at Ϫ70°C. Organs or tissues were homogenized and analyzed by LC-MS/MS method.
Pharmacodynamics Study Two days after surgery, 60 tumor-bearing mice were divided into four groups randomly. Soon after the anesthetization by injecting pentobarbital into the abdominal cavity at a dose of 50 mg/kg, the mice were IV injected with ts-lip-ADM, lip-ADM, ADM and saline solution at a drug dose of 10 mg/kg. After administration the heads of mice were heated in water bath at 42°C for 30 min. For every 3 d, the same anesthetization and treatment procedure were repeated twice. In the course of survival experiments, animation of mice was observed, including body weight, food intake, breath, vigilance, pelage, etc.
Statistical Analysis Data were expressed as meanϮstan-dard deviation in the figures and tables, with pϽ0.05 regarded as statistically significant. Statistical tests were performed with the Student t-test, the Wilcoxon signed rank test, or the Mann-Whitney test. When differences were detected, the Wilcoxon signed rank test was used to test for pairwise differences between treatment groups and the Mann-Whit-
ney test was used to determine the difference between independent sample groups. Survival was assessed with the Kaplan-Meier method.
RESULTS
Characterization of Liposomes
The encapsulation efficiency, average sizes of ts-lip-ADM and lip-ADM were shown in Table 1 . All two kinds of ADM containing liposomes were homogeneous, semitransparent colloid solution. The results showed that number based average diameters of ts-lip-ADM and lip-ADM were about 120 nm. The concentrations of ADM and encapsulation efficiency of the two kinds of liposomes were about 2.0 mg/ml and above 99%, respectively.
DSC represents as the first choice analytical tool for an accurate physicochemical characterization of thermo-sensitive liposomes and is commonly used as a routine method for a rapid preliminary qualitative investigation of T c . It indicated that T c of ts-lip-ADM and lip-ADM were 42.76°C and 52.38°C, respectively. The T c of ts-lip-ADM, which is much lower than that of lip-ADM, makes it quite favorable in clinical thermotherapy.
Temperature-Dependent ADM Release from Loaded Liposomes in Vitro Drug release from ts-lip-ADM and lip-ADM at 37°C and 42°C was investigated. As shown in Fig.  1 , the accumulative release of ts-lip-ADM was below 5% after 30 min at 37°C, which was below T c of ts-lip-ADM. However, when ts-lip-ADM was incubated at temperature above T c of ts-lip-ADM (42°C), a large amount of drug was released from ts-lip-ADM rapidly. The accumulative release was about 90% for 42°C after 30 min. By contrast, there was only little amount of drug released from lip-ADM at 37°C or 42°C.
Evaluation of the BBB Model
The in vitro BBB model was evaluated by TEER and permeability. , and it could maintain this level in 2-3 d. However, the maximum TEER of ECV304 alone was only about 49 W· cm 2 , which was much lower than that of in vitro BBB model. Figure 3 showed the permeability of ADM on the in vitro BBB model. The permeability of ADM displayed that it was 2.86% on the confluent ECV304 at 7 d, and only 1.22% on the confluent ECV304/As.
Transport Measurements of ADM Liposomes on the in Vitro BBB Model When the ECV304/As was confluent, which was judged by TEER primarily, they were employed to evaluate the permeability of ts-lip-ADM and lip-ADM across the in vitro BBB model. The effect of liposomes on the permeability of ADM was shown in Fig. 4 . The results showed that the permeability of free ADM was about 1-2ϫ10 Ϫ5 cm/min, it just slightly increased when temperature rising to 42°C. The permeability of ADM increased after ADM was incorporated into liposomes. At different time points, the permeability of lip-ADM was 2-4 fold to that of free ADM at 37°C or 42°C. Compared with the permeability of lip-ADM at 37°C, the permeability of lip-ADM at 42°C increased about 50%. It was interesting that the permeability of ts-lip-ADM at 37°C was higher than that of lip-ADM at higher temperature (42°C). The permeability of ts-lip-ADM could be increased significantly after the temperature was raised to 42°C, which was about 10-16, 22-38, 38-45, 50-105 fold to that of ts-lip-ADM (37°C), lip-ADM (42°C), lip-ADM (37°C) and free ADM, respectively. Table 2 showed the TEER values of the in vitro BBB models before/after heating at 42°C. Obviously, the TEER values of the in vitro BBB heated at 42°C for 2 h were approximate to that before treatment. It suggested that the permeability of the in vitro BBB models was no change after heating.
Body Distribution The heads of glioma-bearing mice were heated in water bath at 42°C for 30 min after intravenous administration. Figure 5 showed the distribution of tslip-ADM, lip-ADM and ADM solution after 0.5, 1, 2 h of administration, respectively. The clearance of ADM solution in the blood was faster than that of ts-lip-ADM and lip-ADM, which indicated that there was adequate retention of drug within liposomes in the circulation. The distribution of ADM in the brain at 0.5, 1, 2 h was shown in Fig. 6 . The drug concentration in the brain of each group decreased gradually. The maximum brain concentration of ts-lip-ADM was 6.4, 3.7 fold compared with that of ADM solution and lip-ADM, respectively. The results indicated that thermosensitive liposomes combined hyperthermia could significantly enhance the enrichment of ADM in brain. Figure 7 showed the results of survival time of four groups. Mice treated with saline or ADM solution went to death at 13th or 14th day, its survival time was about 25 and 27 d, respectively. The lip-ADM group's survival time of mice was longer than that of saline group and ADM group. The survival time of mice administered ts-lip-ADM (44 d) was remarkably longer than that of other three groups. Table 3 showed that the ts-lip-ADM group's median survival time of mice was significantly longer than that of saline group,ADM solution group and lip-ADM group. It suggested that thermosensitive liposomes combined with hyperthermia could prolong the survival time of glioma-bearing mice.
Pharmacodynamics Study
DISCUSSION
A primary in vitro BBB model had the advantages of being an in vitro technique and was a useful tool for studying the CNS drug delivery across the BBB. It was thoroughly demonstrated that the formation of the function of BBB was not inherent property of brain microvascular endothelial cells (BMVEC), it was induced by astrocytes. 17) Astrocytes played key roles in inducing and maintaining the integrity of BBB. But there was a gap of 2-3 nm between astrocytes and BMVEC. 18) When ECV304 and astrocytes were cocultured in a "contact through feet" model, two kinds of cells could interact through secreted substances without direct contact. When ECV304 cultured on the upper side of PET membrane was confluence, the maximum TEER of in vitro BBB model achieved and maintained in a few days. There was correlation between the TEER and BBB permeability: the TEER was higher and the permeability was lower.
After the BBB was formed, the permeability of ts-lip-ADM, lip-ADM and ADM combined hyperthermia treatment were investigated. As a result, when temperature rising, (a) the permeability of each group was enhanced, (b) while the permeability of ADM and lip-ADM increased slightly, the promotion of ts-lip-ADM was remarkable. When the temperature was raised to 42°C, the intercellular space of the blood vessel endothelial cells may be incompact and the permeability of the in vitro BBB model was enhanced. But this change was slight and temporary, and the integrity of the in vitro BBB was not damaged. Therefore, this change was not enough for large amount of hydrophilic drug across the BBB. The permeability of free ADM at 42°C was approximate to that at 37°C and the TEER values of the in vitro BBB were no change evidently after heat treatment. Because the structure of liposomes was similar to that of the cell, the permeability of lip-ADM, as compared with that of free ADM, increased. But there was no much difference between the permeability of lip-ADM at 37°C and at 42°C. So heat treatment (42°C) just slightly enhanced the permeability of common lipsomes across the in vitro BBB. It was important that thermosensitive liposomes combined with heat treatment could significantly enhance the permeability of drug across BBB. Similar results were obtained with another drug, vinorelbine bitartrate (data not shown). As mentioned above, the permeability enhancement of the in vitro BBB model may make small contribution to this promotion. The main reason may be due to the property of thermosensitive liposomes. Even at 37°C, the permeability of ts-lip-ADM was higher than that of lip-ADM at 42°C. Heat treatment may enhance the interaction between endothelial cell and thermosensitive liposomes. We presumed that the higher temperature resulted in the more fluidity of the membrane of ts-lip-ADM and the cell. Then the effect of confluence and permeation on the BBB was strengthened. In this study, the results in vivo were consistent with results in vitro. Biodistribution study demonstrated that the distribution of two kinds of liposomes were similar, but different from ADM solution. The life time of ADM encapsulated in liposomes in blood was prolonged. Hence, it indicated that the body distribution of ADM liposomes mainly depended on the distribution behavior of the liposomes in vivo. What is different from lip-ADM was that ts-lip-ADM combined with hyperthermia had significantly enhanced drug delivery across BBB and resulted in higher drug concentration in brain. Except reasons mentioned above, in vivo, when temperature rising, ts-lip-ADM could rapidly release large amount of drug in local region of brain. Moreover thermosensitive liposomes had an enhanced permeation and retention effect for tumor vasculature combined with hyperthermia treatment.
11) All of these factors could provide higher concentration gradient and enhance drug delivery across BBB. So the survival time of glioma implanted mice treated by ts-lip-ADM was prolonged.
In conclusion, the results in vitro and in vivo all demonstrated that ADM-encapsulated thermosensitive liposomes combined hyperthermia could enhance ADM delivery across BBB and prolong survival time of glioma-bearing mice. 
